pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,336 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: pdufa×type: earnings×type: phase readout×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Dermatology1
    • Infectious Disease1

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05778825: A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Survivors of Childhood Cancer, Alopecia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06007976: LLLT to Reduce Low Back Pain

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Low Back Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06445140: Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics

    Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02761889: Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

    Sponsor: Fundacao Champalimaud. Phase: NA. Conditions: Adenocarcinoma of the Prostate

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07500090: A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

    Sponsor: Harmony Biosciences Management, Inc.. Phase: PHASE3. Conditions: Idiopathic Hypersomnia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07084090: Using IF-THEN Plans to Support Patients in Raising Safety Concerns About Their Care

    Sponsor: University of Manchester. Phase: NA. Conditions: Patient Safety Concerns

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06118697: Feasibility of Aerodigestive Stimulation Therapy Trial

    Sponsor: Sudarshan Jadcherla. Phase: NA. Conditions: Feeding Disorder Neonatal

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05780710: OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake

    Sponsor: Aktiia SA. Phase: NA. Conditions: Hypertension

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07412613: Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

    Sponsor: Akeso. Phase: PHASE3. Conditions: Resectable Colon Cancer, MSI-H/dMMR Colorectal Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05937620: Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

    Sponsor: Fundacion Clinic per a la Recerca Biomédica. Phase: NA. Conditions: Ovarian Epithelial Cancer

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04717024: The Nanowear Wearable Covid-19 Observational and Analysis Trend

    Sponsor: Nanowear Inc.. Phase: . Conditions: Covid19

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06381024: A Study of Telemonitoring in Cancer Patients

    Sponsor: Centre Hospitalier de Bligny. Phase: NA. Conditions: Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06469970: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults

    Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: PHASE2. Conditions: Burns, Intensive Care, Emergencies

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06963970: Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Dementia, Cancer, Renal Disease, Obstructive Pulmonary Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07432373: Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection

    Sponsor: National University of Malaysia. Phase: . Conditions: Pleural Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07612969: Comparing The Effect of Proprioceptive Neuromuscular Facilitation (PNF) When Coupled With Dry Needling (DN), Acupuncture (AN) or Sham Needling (SN) on Knee Range of Motion (ROM), Jump Height and Unipedal Balance

    Sponsor: Mohamad Karam. Phase: NA. Conditions: Healthy Adult Males, Healthy Subjects

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07572669: Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

    Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: PHASE2. Conditions: Steroid-Refractory Acute Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Graft-Versus-Host Disease, Allogeneic Hematopoietic Stem Cell Transplantation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07593183: Comparing the Effects of Lumbar Stability Exercises and Telerehabilitation on Reducing Lumbar Lordotic Angle, Pain, and Disability in Postpartum Women

    Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Lumbar Lordotic Angle, Lumbar Pain, Disability

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07406841: Spinal Versus General Anesthesia in Pregnancies With Placenta Accreta Spectrum: A Retrospective Comparative Study

    Sponsor: Gaziantep City Hospital. Phase: . Conditions: Placenta Accreta Spectrum

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07504341: Physiological Finding in Management of COVID 19 Patients

    Sponsor: St. Martin De Porress Hospital. Phase: . Conditions: COVID-19 (Coronavirus Disease 2019)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07306754: A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

    Sponsor: AbbVie. Phase: PHASE1. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT05396105: Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

    Sponsor: Pharvaris Netherlands B.V.. Phase: PHASE2. Conditions: Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II, Hereditary Angioedema Attack, Hereditary Angioedema With C1 Esterase Inhibitor Deficiency, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, Hereditary Angioedema - Type 3, C1 Esterase Inhibitor [C1-INH] Deficiency, C1 Esterase Inhibitor Deficiency, C1 Esterase Inhibitor, Deficiency of, C1 Inhibitor Deficiency, Hereditary Angioedema Type III, Hereditary Angioedema (HAE), Hereditary Angioedema Type I and II

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07541105: Cancer Awareness Among Syrian Migrants

    Sponsor: Toros University. Phase: NA. Conditions: Breast Cancer Screening, Cervical Cancer Screening, Colorectal Cancer Screening, Cancer Prevention Behavior

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07531394: Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke

    Sponsor: Capital Medical University. Phase: PHASE3. Conditions: Ischemic Stroke, Acute, Myocardial Injury

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05535166: Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

    Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Medulloblastoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07461766: Food and Nutrition Education for Adolescent Soccer Players

    Sponsor: Federal University of São Paulo. Phase: NA. Conditions: Nutritional Assessments, Adolescent Athletic Performance, Premenstrual Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03524222: Home Hospital for Suddenly Ill Adults

    Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Infection, Heart Failure, COPD, Asthma, Gout Flare, Chronic Kidney Diseases, Hypertensive Urgency, Atrial Fibrillation Rapid, Anticoagulants; Increased

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05656651: Acute Immunological Effects of Exercise in Cancer Patients

    Sponsor: Universität Duisburg-Essen. Phase: PHASE2. Conditions: Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07473531: Chatbot to Support Healthcare Professionals Experiencing Workplace Aggression

    Sponsor: Distrito Sanitario Almeria. Phase: . Conditions: Workplace Violence, Health Professionals, Chatbot, Digital Health

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07427472: "Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"

    Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Heterozygous Familial Hypercholesterolemia (HeFH)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07465939: Dento-skeletal Effects of Quadhelix Versus Mini-hyrax Expanders in Patients With Cleft Lip and Palate at the Mixed Dentition Stage: A Randomized Clinical Trial

    Sponsor: Cairo University. Phase: NA. Conditions: Maxillary Expansion in Cleft Lip and Palate Patients, Dentoskeletal Effects After Expansion Using Two Different Expanders

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07569575: Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures

    Sponsor: HuaMg Perfection Med Tech (Suzhou) Co., Ltd.. Phase: NA. Conditions: Tibial Fracture, Femoral Fracture, Humeral Fracture

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07422675: SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

    Sponsor: Serina Therapeutics. Phase: PHASE1. Conditions: PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07439575: Wound Closure Materials and Techniques in Hip and Knee Arthroplasty

    Sponsor: Bahattin Kemah. Phase: NA. Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06851975: Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment

    Sponsor: Centre Antoine Lacassagne. Phase: . Conditions: Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06503575: Adolescent Idiopathic Scoliosis and Body Schema

    Sponsor: Acibadem University. Phase: . Conditions: Adolescent Idiopathic Scoliosis, Body Schema

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06783595: Peri-implant Mucosal Changes Over Time Following Implant Provisional Removal in the Esthetic Zone

    Sponsor: Loma Linda University. Phase: . Conditions: Tooth Loss, Implant Site Reaction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07477067: Exercise and Protein Efficiency in T2D

    Sponsor: University of Illinois at Urbana-Champaign. Phase: NA. Conditions: Type 2 Diabetes, Control Condition

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06805630: Urine Methylation Markers in UTUC

    Sponsor: Duke University. Phase: NA. Conditions: Upper Tract Urothelial Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05603000: Emotion Focused Family Therapy for Parents of Children With Mental Health Difficulties

    Sponsor: University of Guelph. Phase: NA. Conditions: Anxiety, Depression, Behavior Problem

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06477900: Impact of SMS Reminder on Weight Loss, as Part of a Health Pathway in Patients With Prediabetes (PREDIABCOACH)

    Sponsor: Centre Hospitalier Universitaire de la Réunion. Phase: NA. Conditions: PreDiabetes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06445400: A Study of BL-M07D1, BL-M07D1+Pertuzumab and BL-M07D1+Pertuzumab+Docetaxel in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

    Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: HER2-positive Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07359807: A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.

    Sponsor: Concept Medical Inc.. Phase: PHASE2. Conditions: Popliteal Artery Disease, Superficial Femoral Artery Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04928807: Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

    Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: PHASE3. Conditions: Rectal Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07582107: Anatomical Landmark Method for Paediatric Port Catheter Tip Positioning

    Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: Central Venous Catheterization, Vascular Access Devices, Pediatric Patients, Monitoring

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07552792: Impact of Hand Rub Placement on Patient Trust and Disease Stigma

    Sponsor: Huashan Hospital. Phase: NA. Conditions: Noncommunicable Disease, Psoriasis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07379034: The Effect of ShotBlocker and Vibration on Pain During Vaccination

    Sponsor: Ataturk University. Phase: NA. Conditions: Vaccination, Pain, Infant, Shotblocker, Vibration

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02432534: Atorvastatin in Active Vitiligo

    Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE2. Conditions: Vitiligo

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06017934: Promoting Increased Physical Activity in Hospitalised Older Adults

    Sponsor: University of Southampton. Phase: NA. Conditions: Hospital-associated Deconditioning

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06332209: Randomized Trial of Tele Vs. Clinic TF-CBT in Puerto Rico

    Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Post-Traumatic Stress Disorder

    full page →ctgov ↗
    ← prev
    page 49 of 107
    next →